Early Feasibility Study of the MyoRegulator® for Treatment of ALS

NCT06165172 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DEVICE: MyoRegulator®

Sponsor

PathMaker Neurosystems Inc.

Collaborators

[object Object]
[object Object]
[object Object]